Pathogenesis of hypertension in renal failure: Role of the sympathetic nervous system and renal afferents

被引:37
作者
Phillips, JK [1 ]
机构
[1] Murdoch Univ, Div Hlth Sci, Murdoch, WA 6150, Australia
关键词
autonomic nervous system; efferent; muscle sympathetic nerve activity; polycystic kidney disease; renin-angiotensin-aldosterone system; renovascular hypertension;
D O I
10.1111/j.1440-1681.2005.04204.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The kidney receives a dense innervation of sympathetic and sensory fibres and can be both a target of sympathetic activity and a source of signals that drive sympathetic tone. In the normal state, interactions between the kidney and sympathetic nervous system (SNS) serve to maintain blood pressure and glomerular filtration rate within tightly controlled levels. In renal failure, a defect in renal sodium excretory function leads to an abnormal pressure natriuresis relationship and activation of the renin-angiotensin-aldosterone system, contributing to the development of hypertension and progression of kidney disease. 2. Evidence now strongly indicates a role for the SNS in the pathogenesis of hypertension in renal failure. Hypertension occurs commonly and early in renal disease and is paralleled by increases in SNS activity, as indicated by increased muscle sympathetic nerve activity and circulating catecholamines. This appears to be driven by the diseased kidneys, because nephrectomy or denervation has been shown to correct blood pressure and SNS activity in human and animal studies. 3. Afferent signals from the kidney, detected by chemoreceptors and mechanoreceptors, feed directly into central nuclei of the SNS, including the hypothalamus and circumventricular organs, in addition to the stimulus provided by circulating and brain-derived angiotensin II. Therefore, the pathogenesis of hypertension in renal failure is complex and arises from the interaction of haemodynamic and neuroendocrine factors. 4. Increased SNS activity has significant implications with regard to increased risk of cardiovascular disease and is an important consideration in the treatment of renal failure.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 50 条
[1]   Kidney and hypertension [J].
Adamczak, M ;
Zeier, M ;
Dikow, R ;
Ritz, E .
KIDNEY INTERNATIONAL, 2002, 61 :S62-S67
[2]   Hypothalamic paraventricular nucleus inhibition decreases renal sympathetic nerve activity in hypertensive and normotensive rats [J].
Akine, A ;
Montanaro, M ;
Allen, AM .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2003, 108 (1-2) :17-21
[3]   Endothelial-derived vasoactive mediators in polycystic kidney disease [J].
Al-Nimri, MA ;
Komers, R ;
Oyama, TT ;
Subramanya, AR ;
Lindsley, JN ;
Anderson, S .
KIDNEY INTERNATIONAL, 2003, 63 (05) :1776-1784
[4]   Sympathetic overactivity as a cause of hypertension in chronic renal failure [J].
Augustyniak, RA ;
Tuncel, M ;
Zhang, WG ;
Toto, RD ;
Victor, RG .
JOURNAL OF HYPERTENSION, 2002, 20 (01) :3-9
[5]   ANATOMY OF THE RENAL INNERVATION - INTRARENAL ASPECTS AND GANGLIA OF ORIGIN [J].
BARAJAS, L ;
LIU, L ;
POWERS, K .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (05) :735-749
[6]   Sympathetic nervous system and chronic renal failure [J].
Boero, R ;
Pignataro, A ;
Ferro, M ;
Quarello, F .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2001, 23 (1-2) :69-75
[7]   A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications [J].
Vito M. Campese .
Journal of Clinical and Experimental Nephrology, 2003, 7 (3) :167-171
[8]   RENAL AFFERENT DENERVATION PREVENTS HYPERTENSION IN RATS WITH CHRONIC-RENAL-FAILURE [J].
CAMPESE, VM ;
KOGOSOV, E .
HYPERTENSION, 1995, 25 (04) :878-882
[9]   Neurogenic factors in renal hypertension [J].
Campese, VM ;
Krol, E .
CURRENT HYPERTENSION REPORTS, 2002, 4 (03) :256-260
[10]  
Campese VM, 2000, J NEPHROL, V13, P221